Plasma procalcitonin concentrations are increased in dogs with sepsis
Authors:
Open Access
- 1 March 2018
- journal article
- research article
- Published by Wiley in Veterinary Record Open
- Vol. 5 (1) , e000255
Abstract
Sepsis, the life‐threatening organ dysfunction caused by a dysregulated host response to infection, is difficult to identify and to prognosticate for. In people with sepsis, procalcitonin (PCT) measurement aids diagnosis, enables therapeutic monitoring and improves prognostic accuracy. This study used a commercial canine PCT assay to measure plasma PCT concentrations in dogs with gastric dilatation volvulus (GDV) syndrome and in dogs with sepsis. It was hypothesised that dogs with GDV syndrome and with sepsis have greater plasma PCT concentrations than healthy dogs and that dogs with sepsis have greater PCT concentrations than dogs with GDV syndrome. Before analysing canine plasma samples, the ability of the assay to identify canine PCT, in addition to assay imprecision and the lower limit of detection were established. The assay had low imprecision with coefficients of variation ≤4.5 per cent. The lower limit of detection was 3.4 pg/ml. Plasma PCT concentrations were measured in 20 dogs with sepsis, in 32 dogs with GDV syndrome and in 52 healthy dogs. Median (IQR) PCT concentration in dogs with sepsis 78.7 pg/ml (39.1–164.7) was significantly greater than in healthy dogs 49.8 pg/ml (36.2–63.7) (P=0.019), but there were no significant differences between PCT concentrations in dogs with GDV syndrome and controls (P=0.072) or between dogs with sepsis and GDV syndrome (P=1.000). Dogs with sepsis have significantly increased plasma PCT concentrations compared with healthy dogs, although considerable overlap between these populations was identified. Future investigations should confirm this finding in other populations and evaluate the diagnostic and prognostic value of PCT in dogs with sepsis.Keywords
Funding Information
- Università di Bologna
- College of Veterinary Medicine, Cornell University
- National Institutes of Health
This publication has 36 references indexed in Scilit:
- Evaluation of CALC‐I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndromeJournal of Veterinary Emergency and Critical Care, 2010
- Sepsis biomarkers: a reviewCritical Care, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialCritical Care, 2009
- Procalcitonin has bioactivity at calcitonin receptor family complexes: Potential mediator implications in sepsis*Critical Care Medicine, 2008
- SIRS INCREASES CIRCULATING PROCALCITONIN IN DOGSShock, 2006
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- Procalcitonin increase after endotoxin injection in normal subjectsThe Journal of Clinical Endocrinology & Metabolism, 1994
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993